PRUDENTIAL FINANCIAL INC

Position in FTRE — Fortrea Holdings Inc.

CIK 1137774 NEWARK, NJ

Position in FTRE

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$890,651

-$585,241 QoQ

Shares Held

94,549

+10.5% QoQ

Ownership

0.100%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRUDENTIAL FINANCIAL INC holds $506,574,956 across 170 Biotechnology names. FTRE ranks #67 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	140,491	$108,548,965
2	VRTX	Vertex Pharmaceuticals Inc / Ma	131,560	$58,746,801
3	INCY	Incyte Corp	374,280	$35,227,233
4	EXEL	Exelixis, Inc.	463,825	$19,893,454
5	LGND	Ligand Pharmaceuticals Inc	64,133	$12,804,153
6	ALMS	Alumis Inc.	538,733	$11,868,287
7	PTCT	Ptc Therapeutics, Inc.	164,570	$11,212,154
8	PTGX	Protagonist Therapeutics, Inc	95,235	$10,037,769

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$890,651	94,549	+10.5%	Shares	Defined	2026-05-13
2025-12-31	$1,475,892	85,559	-9.9%	Shares	Defined	2026-02-13
2025-09-30	$799,613	94,966	-0.4%	Shares	Defined	2025-11-13
2025-06-30	$471,014	95,347	-16.3%	Shares	Defined	2025-08-12
2025-03-31	$860,398	113,960	+10.8%	Shares	Defined	2025-05-13
2024-12-31	$1,917,872	102,835	+13.0%	Shares	Defined	2025-02-11
2024-09-30	$1,819,520	90,976	-3.3%	Shares	Defined	2024-11-14
2024-06-30	$2,195,872	94,082	-4.8%	Shares	Defined	2024-08-13
2024-03-31	$3,967,958	98,853	-2.5%	Shares	Defined	2024-05-14
2023-12-31	$3,539,348	101,414	-0.9%	Shares	Defined	2024-02-13
2023-09-30	$2,925,185	102,315	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.